Life sciences

  • Cancer expert calls for governments and health systems to embrace ‘undervalued’ radiotherapy

    A leading cancer expert is challenging widespread misconceptions about radiotherapy which she says is marginalised by healthcare systems despite contributing to 40 per cent of cancer cures. Professor Pat Price, visiting professor at Imperial College London and chair of both Radiotherapy UK and the Global Coalition for Radiotherapy (GCR), has authored a comprehensive report highlighting [...]

  • Opinion: The next drug revolution will be algorithmic

    By Sergey Jakimov and Artem Trotsyuk, managing and operating partners, LongeVC Artificial intelligence is rapidly rewriting medicine – from clinics to labs – and scientists, startups, regulators, and investors are shaping that shift together. The global healthcare AI market is projected to soar from just over $1 billion in 2016 to more than $28 billion [...]

  • Thousands of Scots to receive free weight-loss jabs

    Thousands of Scots in deprived areas will be offered free weight-loss injections in a government-funded trial launching next year. The UK government has provided an initial £650,000 for up to 5,000 participants in the Scotland CardioMetabolic Impact Study (SCoMIS). The multi-million pound study will be led by Glasgow University in partnership with the Universities of [...]

  • Is digital twin technology a viable route to treating pain?

    By Prof Mick Thacker, Dr Kate Ryan and Leslie Pan Pain, particularly musculoskeletal (MSK) pain, is both pervasive and complex. Globally, approximately 1.71 billion people suffer from MSK conditions, which account for the leading cause of disability worldwide, with lower back pain being the single biggest contributor across 160 countries [1]. In the UK alone, [...]

  • Reforming drug pricing key for UK’s life sciences ambitions, warns GSK leader

    Britain will struggle to be a life sciences superpower without reforming drug pricing, GSK’s outgoing chief executive has warned. Emma Walmsley said she was “hopeful and ambitious” that the standoff between the pharmaceutical industry and government could be resolved, as ministers draw up proposals to increase NHS spending on new medicines by up to 25 [...]

  • Experts weigh targeted prostate cancer screening to cut UK deaths

    Prostate cancer screening could reduce deaths by 13 per cent, research has revealed, prompting UK experts to assess whether to introduce a national screening programme. Cancer screening specialists are reviewing the evidence, with a decision expected before the end of the year on whether routine prostate testing should be introduced across the UK. A new [...]

  • New study may transform diagnosis of Britain’s number one cancer

    A major new study, which has recently begun recruiting, is hoped to lead to earlier detection of lung cancers. People living in Leeds, Bath, Hull and Stoke-on-Trent will be among those approached to take part. The study is funded by National Institute for Health and Care Research (NIHR). Professor Anthony Gordon is programme director for [...]

  • Oxygen deprivation heightens risk of illness by changing genes, study reveals

    Low oxygen levels can alter immune cell genes, weakening the body’s ability to fight infection even after oxygen levels return to normal, new research has revealed. Scientists found that oxygen deprivation – known as hypoxia – changes the genetic material of neutrophils, white blood cells that form one of the body’s first lines of defence [...]

  • Smith+Nephew comparative study shows PICO◊ sNPWT (-80 mmHg) delivers superior performance in relation to wound dehiscence and reduces healthcare costs across cardiovascular and orthopedic surgery versus Prevena -125 mmHg sNPWT

    Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, has announced findings from a newly published, first-of-its-kind comparative study of single-use negative pressure wound therapy (sNPWT) devices in orthopedic and cardiovascular surgery. Analysing real-world data from over 22,000 patients in the Premier PINC AI™ Healthcare Database, the analysis reveals that prophylactic use of PICO sNPWT (-80 [...]

  • Pharmaceutical Press to showcase essential drug interactions resource at Global Health Exhibition 2025

    Pharmaceutical Press, the Royal Pharmaceutical Society’s knowledge business, will showcase Stockley's Drug Interactions, practical evidence-based information to manage drug interactions safely and effectively, at this year’s Global Health Exhibition in Riyadh, highlighting its crucial role in addressing medication errors. As part of the Association of British HealthTech Industries (ABHI) UK Pavilion (Hall 3, Stand L40), [...]